C.RIS Pharma (C.RIS) is a Contract research organization. It is principally engaged in preclinical development of new molecules. It is specialized in the preclinical development of new active molecules in the fields of cancer, metabolic, neurodegenerative and genetic diseases and partner for cosmetic, agrofood and veterinary companies. In addition, it possesses various models for in vitro and in vivo screening and pharmacology assays for the evaluation of molecules in antitumor activities, chemotherapy, diabete, inflammation, allergy, dermatology and neuronal diseases. It is developing its pipeline on new methods such as drug mechanism and profile gene expression. The Organisation offers range of services namely, characterization of molicule activity, identification and validation of therapeutic target, toxicology and metabolism, cosmetic studies and agrofood studies. C.RIS Pharma is headquartered in Saint Malo, France.